From Wellbutrin to Ozempic, prescription prices are on the rise — how to mitigate costs

Published 3 Min Read

Two Ozempic injection pens and the box.
mbruxelle from AdobeStock

Given that the U.S. has a profit-centered healthcare system, it’s not surprising to see substantial increases in medication prices, whether it’s a weight-loss drug or blood thinners. But this is a reality that employers may need to start actively working against if they want a health plan employees can actually afford.

Nonprofit research company 46 Brooklyn found that pharmaceutical companies are raising prices for over 700 medications in January alone, with the average increase sitting at about 4.5%. Popular weight-loss drug Ozempic, for example, will see a price hike of 3.5%, while the antidepressant Wellbutrin will increase by 9.9%. Comparatively, an estimated 24 medications will drop in price, with insulin leading the pack after Medicare capped monthly prices were at $35. 

Deanna Cuadra
Senior Reporter

Deanna Cuadra is a senior reporter at Employee Benefit News. Her work covers healthcare, U.S. policy and reform, challenges faced by women and parents in the workplace and innovation in work culture … Read full bio


For reprint and licensing requests for this article, click here.


More From Employee Benefit News

Sign Up Form

Login Modal Form